Chloride Channels

OADS is a selective inhibitor of the chloride channel antiporter ClC-ec1, exhibiting an IC50 value of 29 μM. This compound specifically interferes with the ClC-ec1 antiporter pathway, while showing no inhibitory effects on the ClC-1 channel. OADS is utilized in research related to osteoporosis, as well as various neurodegenerative and cardiovascular diseases, facilitating the study of these critical health conditions.

Lubiprostone (hemiketal) is a selective activator of chloride channel 2 (CLCN2). It effectively increases chloride ion secretion in the intestine, enhancing fluid secretion and promoting intestinal peristalsis, making it valuable for studying chronic idiopathic constipation and opioid-induced constipation. This compound is also applicable in cancer research, providing insights into gastrointestinal function and potential therapeutic interventions.

4''-Oxoavermectin B1a is a potent modulator of GABA (γ-aminobutyric acid) and glutamate-gated chloride channels, exhibiting significant insecticidal and acaricidal properties. This compound demonstrates efficacy in disrupting neurological processes in target pests, making it a valuable tool for research in agricultural pest management. Its application contributes to understanding the mechanisms of action in pest control strategies.

TMEM16A modulator-1 is a positive modulator of the calcium-activated chloride channel TMEM16A. This compound enhances the activity of TMEM16A, making it valuable for investigating its roles in various biological processes. It is particularly relevant for research into TMEM16A-related diseases, such as respiratory disorders, where modulation of ion channels may reveal therapeutic possibilities.

Cobiprostone is a type-2 chloride channel activator known for its protective effects against NSAID-induced cellular damage. It effectively prevents Indomethacin-induced depolarization of mitochondrial membrane potential and reverses subsequent loss of membrane integrity. This compound is valuable for research focused on mitochondrial function and cellular responsiveness to ion channel modulation.

NS3736 is an orally bioavailable inhibitor of chloride channels, specifically targeting the CIC-7 channel in osteocytes. This compound effectively blocks osteoclast acidification and resorption in vitro, exhibiting an IC50 of 30 μM. In preclinical studies using a rat model of ovariectomy-induced osteoporosis, NS3736 has demonstrated the ability to enhance bone strength and increase bone density, making it a valuable tool for researching osteoporosis.

Unoprostone is an activator of BK (large conductance Ca2+-activated K+) channels and ClC-2 chloride channels. This compound has demonstrated the ability to protect retinal cells from oxidative stress and light-induced damage, while also improving phagocytic function. Additionally, Unoprostone effectively reduces intraocular pressure, making it a valuable tool for research into glaucoma, ocular hypertension, and retinitis pigmentosa.

BTG 1640 is a potent anxiolytic agent classified as an isoxazoline. It selectively inhibits GABA- and glutamate-gated chloride channels, contributing to its anxiolytic effects. This compound is of significant interest in neuropharmacological research for studying anxiety disorders and their treatment mechanisms.

Leptophos oxon is a potent GABAA receptor chloride channel inhibitor, exhibiting an IC50 value of 89.6 μM. This compound effectively inhibits GABA-induced chloride influx through binding to the TBPS sites associated with GABAA receptors, as well as inhibiting TBPS binding to voltage-dependent chloride channels. Leptophos oxon is primarily utilized in studies related to neurological diseases and functions as an insecticide, making it relevant for research in both neurobiology and pest management.

NS5818 is a potent chloride channel inhibitor that effectively disrupts acidification and bone resorption processes. Its mechanism of action makes it a valuable tool for studying osteoporosis and associated bone metabolic disorders. Researchers can utilize NS5818 to gain insights into chloride channel functions and their implications in bone health.

Alilusem potassium is a selective chloride channel inhibitor known for its diuretic properties. Studies have demonstrated its effectiveness in reducing free water clearance while enhancing sodium and chloride excretion in urine during water diuresis in anesthetized canine models. Additionally, Alilusem potassium, when administered with Furosemide or Hydrochlorothiazide, further diminished free water clearance. This compound has also been shown to inhibit lumen-positive transepithelial voltage and chloride flux across isolated rabbit cortical thick ascending limbs of Henle, making it a valuable tool for research in renal physiology and electrolyte transport mechanisms.

Niflumic Acid-d5 is a deuterium-labeled derivative of Niflumic acid, which acts primarily as a calcium-activated chloride channel blocker. This compound exhibits significant analgesic and anti-inflammatory properties, making it useful in the management of conditions such as rheumatoid arthritis. Its stable isotope form is valuable for research applications in pharmacokinetics, metabolic studies, and mechanistic investigations of calcium channel modulation.

Nipecotic acid is a potent inhibitor of GABA uptake in neurons and glial cells, significantly impacting GABAergic neurotransmission. This compound has also been shown to directly activate GABAA-like chloride channels, with an effective concentration (EC50) of approximately 300 μM. Its biological activity makes nipecotic acid valuable for research applications focused on GABAergic signaling and associated neurological processes.

Tedisamil is an antiarrhythmic agent primarily targeting the transient outward potassium current (I(to)) in the atrium, leading to a significant reduction in heart rate. This compound also inhibits various potassium currents, including IK and K(ATP), as well as PKA-activated chloride channels, ultimately prolonging the cardiac action potential and QT interval. Tedisamil demonstrates effective antiarrhythmic properties against ventricular arrhythmias and atrial flutter in preclinical animal models, making it a valuable tool for cardiovascular research.

Tedisamil dihydrochloride is an antiarrhythmic agent primarily targeting the transient outward potassium current (I(to)) in cardiac tissue. This compound significantly slows heart rate by inhibiting multiple potassium channels, including IK, K(ATP), and PKA-activated chloride channels, which prolongs the cardiac action potential and QT interval. Tedisamil dihydrochloride is effective in demonstrating antiarrhythmic effects against ventricular arrhythmias and atrial flutter in various animal models, making it a valuable tool for cardiovascular research.

Adenophostin A is a potent modulator of inositol 1,4,5-trisphosphate receptors (IP3) that functions as a calcium (Ca2+) releaser, exhibiting an IC50 of 1.3 nM and an EC50 of 1.4 nM in rat models. This compound effectively stimulates Ca2+ release from intracellular stores and microsomes, inhibits the binding of [3H]IP3 to plasma membrane receptors, and activates chloride channels. Notably, Adenophostin A is resistant to phosphorylation and dephosphorylation by metabolic enzymes, thereby sustaining its activity and enhancing cytoplasmic Ca2+ levels in vascular smooth muscle cells. This reagent is highly relevant for research on hemorrhagic shock and related physiological studies.

Fluralaner impurity 2 is a drug impurity associated with the insecticide Fluralaner, which primarily targets the GABA and glutamate-gated chloride channels in arthropods. This compound serves as a valuable reference standard for analytical applications in quality control and method development related to Fluralaner synthesis and formulation. Its characterization aids in understanding the impurities' impact on pharmacological efficacy and safety profiles in research and regulatory contexts.

Doramectin aglycone is a drug derivative with potent antiparasitic activity. Primarily targeting glutamate-gated chloride channels, it exhibits effectiveness against a variety of parasites, making it valuable in veterinary medicine and research into antiparasitic drug development. Its biological activity supports studies on mechanisms of action within the context of parasitic infections and resistance.

Fenamic acid (N-Phenylanthranilic acid, NPAA) is a potent chloride channel blocker. It serves as a foundational compound in the synthesis of non-steroidal anti-inflammatory agents (NSAIA) and gives rise to derivatives such as mefenamic, tofenacin, flufenac, and melofenac acids. Additionally, fenamic acid exhibits antibacterial and analgesic properties, making it useful for various biological research applications and studies focused on pain and inflammation pathways.